The GreenWave

Marijuana Rescheduling Could Be Impacted If Trump Replaces Bondi As Attorney General With Zeldin: The former congressman has a mixed record on cannabis, supporting some reform measures and opposing others—while complaining about the smell of marijuana. marijuanamoment.net/marijuana-resc…

🚨#BREAKING: Starting April 20, 2026, the U.S. Army will raise the maximum enlistment age from 34 to 42 years old and remove the waiver requirement for individuals with a single prior conviction for marijuana possession.

Across 2020–2025, the #cannabis industry experienced repeated waves of goodwill + asset impairments due to: 1.) Overpriced acquisitions during the 2018–2021 bubble 2.) Slower-than-expected legalization 3.) Price compression 4.) Overcapacity (greenhouses, cultivation assets) 5.) Declining market caps → forced accounting write-downs 👉 The sector has transitioned from overexpansion → balance sheet repair. The following chart illustrates the cumulative impairment charges (2020 - 2025) as a % of invested capital for the top MSOs. Again, @GTIGrows is the leader having written off only 5% of invested capital defined as equity + debt - cash (at peak level). More on this topic in an upcoming GreenWave Buzz subscribe at greenwaveadvisors.com $MSOS $GTBIF $CURLF $CRLBF $JUSHF $AAWH $TRSSF $VRNOF $TCNNF

Update on my previous ramblings - and this one comes straight from CMS.gov, published late last night. The official Substance Access Beneficiary Engagement Incentive page is live. Here's what it confirms: • April 1. In writing. On a federal government website. Not Mehmet Oz at a podium - CMS.gov. For anyone who was dubious of the April 1 start date, there it is. • Up to 3mg per serving of tetrahydrocannabinols - delta-8, delta-10, THCA - in orally administered products. Confirmed clinical parameter. No synthetics. Naturally occurring cannabinoids only. Someone at CMS wrote that specification deliberately. • Medicare does not pay for the products. ACOs fund up to $500/year per patient voluntarily out of their own shared savings. Patients pay nothing. But here's why that's actually the stronger signal: ACOs are risk-bearing organizations with their own money on the line. When they voluntarily fund cannabinoid therapy, it's because they believe it will reduce hospitalizations and downstream costs. So what was initially presented as a government subsidy is instead a market-based validation of therapeutic efficacy. That's big! But to me the most important line in the entire document (buried in the FAQ) is this one: "If the legal limits on hemp-derived products changes, as with Section 781 of the FY2026 Agriculture Appropriations Act, CMS will adjust its definition in accordance with the law." Read that again. CMS is explicitly acknowledging the November Farm Bill cliff, and rather than saying the program will end, they're saying the definition might adjust. In my opinion, that is not the language of an agency expecting its program to be shut down in eight months, rather the language of an agency anticipating the underlying law to change around it. So the architecture isn't just taking shape - it's now being published on government websites. Happy Sunday. Touch some grass, hug your dog (or your kid / partner / neighbor if you're not lucky enough to have a dog). We are living in heavy times. The news cycle is relentless, the macro is brutal, and if you're a cannabis investor you've been white-knuckling it for years with very little to show for it. So take this small kernel of good news - a government agency quietly publishing a federal program page on a Friday night that confirms, in writing, that progress is real and happening. And let it be enough for today. **Not financial advice. Just a guy reading federal documents so you don't have to.

Marijuana Businesses Can't Force Court To Do 'Imaginary' Rescheduling Review To Exempt Them From 280E Tax, IRS Says: "This would create a seismic rift between how substances are controlled and identified under the CSA." marijuanamoment.net/marijuana-busi…